BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2014
View Archived Issues
Proteasome inhibition rescues a sarcolemmal repair protein in patients with muscular dystrophy
Read More
Generation of a transgenic mouse model of UBQLN2 mutation-related pathologies
Read More
Discovery of a novel TRPV1 antagonist as an analgesic
Read More
Double transgenic mouse model of MS used to assess ATX-MS-1467 effects
Read More
SYN-004, a novel, potent beta-lactamase, protects intestinal microflora in vivo
Read More
Phase IIb data for dupilumab in patients with atopic dermatitis reported
Read More
Novel 5-bromo-indirubins disclosed for non-small cell lung cancer
Read More
Biocept and Rosetta Genomics to evaluate microRNAs from circulating tumor cells
Read More
Cancer Genetics collaborates with Columbia University for myelodysplastic syndromes
Read More
Topline results reported from phase IIa study of LPCN-1111
Read More
Tobira Therapeutics doses first patient in phase IIb CENTAUR trial
Read More
Safety and pharmacokinetic analysis of N-91115 supports once-daily dosing
Read More
FDA accepts palbociclib NDA with priority review
Read More
Bristol-Myers Squibb, Pharmacyclics and Janssen to evaluate Opdivo and Imbruvica in NHL
Read More
Meda completes Rottapharm acquisition
Read More
VSV-EBOV Ebola vaccine begins phase I trials
Read More
Shantha's rotavirus vaccine enters phase III
Read More
Alnylam presents data from phase II extension study of patisiran in FAP
Read More
Novel anti-EGFR repebody for the detection and treatment of EGFR-expressing tumors
Read More
Dynavax Technologies begins phase I/II study of SD-101 in B-cell lymphoma
Read More
New Oncology and Gustave Roussy Cancer Campus collaborate on tumor genome profiling
Read More
Astellas collaborates with Harvard Medical School in retinitis pigmentosa
Read More
